| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |